Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
36.1M
-
Shares change
-
-3.37M
-
Total reported value, excl. options
-
$144M
-
Value change
-
-$45.2M
-
Put/Call ratio
-
0.42
-
Number of buys
-
52
-
Number of sells
-
-53
-
Price
-
$4.00
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2021
157 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.1M shares
of 60M outstanding shares and own 60.12% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.9M shares), BlackRock Inc. (3.23M shares), STATE STREET CORP (3.08M shares), VANGUARD GROUP INC (2.81M shares), MILLENNIUM MANAGEMENT LLC (1.66M shares), EAGLE ASSET MANAGEMENT INC (1.39M shares), Verition Fund Management LLC (1.37M shares), Prosight Management, LP (1.16M shares), GEODE CAPITAL MANAGEMENT, LLC (853K shares), and Woodline Partners LP (776K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.